Pre-treatment waking cortisol response and vulnerability to interferon α induced depression

European Neuropsychopharmacology

Volumn 22, Issue 12, 2012, Pages 892-896

  Eccles, Jessica ^a,c   Lallemant, Camille ^b   Mushtaq, Farrah ^a   Greenwood, Matthew ^b   Keller, Majella ^b   Golding, Bruno ^d   Tibble, Jeremy ^b   Haq, Inam ^a,b   Whale, Richard ^a,c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b Worthing Hospital   (United Kingdom)

^c SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Aetiology; Cytokines; Depression; Hepatitis C virus; HPA axis; Interferon; Neuroendocrinology; Serotonin

Indexed keywords

HYDROCORTISONE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DSM-IV; FEMALE; HAMILTON SCALE; HEPATITIS C; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SALIVA LEVEL;

ADULT; COHORT STUDIES; DEPRESSION; FEMALE; HEPATITIS C; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERFERON-ALPHA; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PROSPECTIVE STUDIES; SALIVA; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; WAKEFULNESS;

EID: 84870701419     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.03.009     Document Type: Article

References (25)

1. Abplanalp J.M., Livingston L., Rose R.M., Sandwisch D. Cortisol and growth hormone responses to psychological stress during the menstrual cycle. Psychosom. Med. 1977, 39:158-177.
2. Adam E.K., Doane L.D., Zinbarg R.E., Mineka S., Craske M.G., Griffith J.W. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology 2010, 35:921-931.
3. Bell C., Abrams J., Nutt D. Tryptophan depletion and its implications for psychiatry. Br. J. Psychiatry 2001, 178:399-405.
4. Bhagwagar Z., Hafizi S., Cowen P.J. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry 2003, 160:1890-1891.
5. Brok J., Gluud L.L., Gluud C. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials. Arch. Intern. Med. 2005, 165:2206-2212.
6. Bull S.J., Huezo-Diaz P., Binder E.B., Cubells J.F., Ranjith G., Maddock C., Miyazaki C., Alexander N., Hotopf M., Cleare A.J., Norris S., Cassidy E., Aitchison K.J., Miller A.H., Pariante C.M. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol. Psychiatry 2009, 14:1095-1104.
7. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B., Miller A.H. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 2003, 160:1342-1345.
8. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7:29-37.
9. Clow A., Hucklebridge F., Stalder T., Evans P., Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 2010, 35:97-103.
10. Cowen P.J. Not fade away: the HPA axis and depression. Psychol. Med. 2010, 40:1-4.
11. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
12. Gisslinger H., Svoboda T., Clodi M., Gilly B., Ludwig H., Havelec L., Luger A. Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 1993, 57:489-495.
13. Herbert J., Goodyer I.M., Grossman A.B., Hastings M.H., de Kloet E.R., Lightman S.L., Lupien S.J., Roozendaal B., Seckl J.R. Do corticosteroids damage the brain?. J. Neuroendocrinol. 2006, 18:393-411.
14. Lotrich F.E., Rabinovitz M., Gironda P., Pollock B.G. Depression following pegylated interferon-alpha: characteristics and vulnerability. J. Psychosom. Res. 2007, 63:131-135.
15. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008, 31:464-468.
16. Pierucci-Lagha A., Covault J., Bonkovsky H.L., Feinn R., Abreu C., Sterling R.K., Fontana R.J., Kranzler H.R. A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment. Psychosomatics 2010, 51:137-148.
17. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61:2539-2549.
18. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
19. Raison C.L., Borisov A.S., Woolwine B.J., Massung B., Vogt G., Miller A.H. Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol. Psychiatry 2010, 15:535-547.
20. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 2000, 92:994-1000.
21. Strickland P.L., Deakin J.F., Percival C., Dixon J., Gater R.A., Goldberg D.P. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br. J. Psychiatry 2002, 180:168-173.
22. Vignau J., Costisella O., Canva V., Imbenotte M., Duhamel A., Lhermitte M. Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients. Encephale 2009, 35:477-483.
23. Wichers M.C., Koek G.H., Robaeys G., Praamstra A.J., Maes M. Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol. Med. 2005, 35:433-441.
24. Wichers M.C., Kenis G., Koek G.H., Robaeys G., Nicolson N.A., Maes M. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J. Psychosom. Res. 2007, 62:207-214.
25. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:722-729.